Prognostic and Immunological Significance of CXCR2 in Ovarian Cancer: A Promising Target for Survival Outcome and Immunotherapeutic Response Assessment

Table 4

The information of the first 20 biological processes enriched by upregulated CXCR2-relevant genes.

Description	GeneRatio	BgRatio	value	FDR	Size
T cell activation	98/670	483/18866	1.24-46	4.26-43	98
Leukocyte cell-cell adhesion	86/670	364/18866	1.85-46	4.26-43	86
Leukocyte proliferation	74/670	313/18866	5.29-40	8.13-37	74
Neutrophil activation involved in immune response	89/670	490/18866	2.89-38	3.32-35	89
Leukocyte chemotaxis	63/670	232/18866	5.31-38	4.89-35	63
Neutrophil degranulation	88/670	487/18866	1.19-37	9.12-35	88
Cell chemotaxis	71/670	311/18866	2.56-37	1.68-34	71
Regulation of leukocyte proliferation	63/670	240/18866	4.88-37	2.81-34	63
Mononuclear cell proliferation	68/670	286/18866	5.87-37	3.00-34	68
Regulation of leukocyte cell-cell adhesion	72/670	329/18866	1.55-36	7.13-34	72
Positive regulation of cytokine production	83/670	447/18866	2.02-36	8.45-34	83
Lymphocyte proliferation	67/670	283/18866	2.69-36	1.03-33	67
Positive regulation of cell adhesion	81/670	428/18866	3.58-36	1.27-33	81
Myeloid leukocyte migration	60/670	222/18866	4.28-36	1.41-33	60
Response to molecule of bacterial origin	74/670	356/18866	6.20-36	1.90-33	74
Regulation of T cell activation	71/670	332/18866	2.43-35	7.00-33	71
Regulation of mononuclear cell proliferation	59/670	221/18866	3.54-35	9.59-33	59
Positive regulation of cell activation	79/670	421/18866	5.21-35	1.33-32	79
Regulation of cell-cell adhesion	80/670	439/18866	1.67-34	4.05-32	80
Regulation of lymphocyte proliferation	58/670	219/18866	2.19-34	5.05-32	58